Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Report on the 19th International Society of Blood Transfusion Platelet Immunology Workshop 2018.

Tytuł:
Report on the 19th International Society of Blood Transfusion Platelet Immunology Workshop 2018.
Autorzy:
Lewin, Antoine
Al Khan, Shadhiya
Beaudin, Lynnette
Meilleur, Lynne
Clarke, Gwen
Richard, Lucie
Temat:
BLOOD platelet transfusion
ANTI-antibodies
LABORATORY management
IMMUNOLOGY
MONOCLONAL antibodies
Źródło:
Vox Sanguinis; Nov2020, Vol. 115 Issue 8, p767-782, 16p, 8 Charts, 2 Graphs
Czasopismo naukowe
Background and objectives: The aims of the 19th International Society of Blood Transfusion Platelet Immunology Workshop were to compare the sensitivity and specificity of in‐house and commercially available methods for the detection of alloantibodies against human platelet antigens. Survey regarding laboratory management of samples collected for the diagnosis of foetal neonatal alloimmune thrombocytopenia was also conducted. Materials and methods: Twenty‐nine laboratories from 17 countries were invited to participate. Seven serum or plasma samples for antibody identification and eight DNA samples for genotyping were sent to participating laboratories. Additionally, samples, critical reagents, materials and instructions for three exercises, one using a commercial kit (Pak Lx), one on platelet preparation for the detection of anti‐HPA‐3 antibodies and one for testing four anti‐CD109 monoclonal antibodies for anti‐HPA‐15 antibody detection, were provided. Results: Anti‐HPA‐1a, anti‐HPA‐2b, anti‐HPA‐5b and anti‐GPIV were detected by the majority of the 28 reporting laboratories using their respective in‐house MAIPA assay and/or a commercially available assay. Conversely, very few laboratories correctly identified anti‐HPA‐3a and HPA‐15b. DNA genotyping of HPA and HLA alleles was highly accurate, with just a few discrepancies relative to the expected results. The Pak Lx kit has proven reliable for detecting anti‐HPA‐1a, anti‐HPA‐5a and anti‐HLA; however, it failed at identifying an anti‐HPA‐3a in a clinical sample. Conclusions: Some anti‐platelet alloantibodies are reliably and consistently detected, yet others remain difficult to detect. Genotyping of HPA and HLA alleles has proven to be highly accurate and robust. Future work should focus on optimizing the detection of anti‐HPA‐3 and anti‐HPA‐15 antibodies. [ABSTRACT FROM AUTHOR]
Copyright of Vox Sanguinis is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies